GlassScriptPhysician profile
Jason M Joseph
NPI 1356550610
$3,075.09
in general payments reported to CMS, 2019-2025
29 companies · $410 in 2025
The $410 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $204 · 2021: $461 · 2022: $631 · 2023: $219 · 2024: $309 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.57 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $642.27 | 2019-2022 | |
| Abbvie INC. | $428.73 | 2019-2023 | |
| Astellas Pharma US INC | $378.55 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $273.28 | 2019-2025 | |
| Pfizer INC. | $236.80 | 2019-2025 | |
| Owens & Minor | $150.91 | 2022 | |
| Therapeuticsmd, INC. | $149.13 | 2019-2022 | |
| Conmed Corporation | $132.81 | 2024-2025 | Airseal |
| Hologic Sales and Service, LLC | $91.88 | 2022-2025 | Novasure, Aptima |
| Organon LLC | $88.70 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $74.72 | 2024-2025 | |
| Allergan, INC. | $61.45 | 2019-2020 | |
| Roche Diagnostics Corporation | $53.15 | 2019-2020 | |
| Alydia Health | $41.61 | 2021 | |
| Millicent US INC | $31.88 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $29.40 | 2025 | Myfembree |
| Coopersurgical, INC. | $28.42 | 2022-2025 | Sos |
| Pacira Pharmaceuticals Incorporated | $21.08 | 2021 | |
| Scynexis, INC. | $18.66 | 2022 | |
| Boston Scientific Corporation | $17.84 | 2024 | Advantage System |
| Evofem Biosciences, INC. | $17.59 | 2022 | |
| Lsi Solutions INC | $17.59 | 2024 | Fornisee |
| Virtus Pharmaceuticals LLC | $16.37 | 2021 | |
| Convatec INC. | $15.07 | 2025 | |
| Meditrina | $12.49 | 2025 | |
| Exeltis, USA INC. | $11.87 | 2022 | |
| Merck Sharp & Dohme LLC | $11.52 | 2019 | |
| Amgen INC. | $11.13 | 2021 | |
| Aspira Women'S Health INC | $10.19 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.